Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Notice to Our Valued Users

Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.

We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.

We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.

If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Benign Hematology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

featured

Published in Benign Hematology

Expert Opinion / Commentary · December 09, 2021

2021 Top Story in Benign Hematology: Building on Data for Voxelotor in Sickle Cell Disease

Written by

Rakhi Naik MD, MHS

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

Additional Info

References

Notice to Our Valued Users

2021 Top Story in Benign Hematology: Building on Data for Voxelotor in Sickle Cell Disease

Additional Info

Further Reading

The Distinctive Blood Film Features of Severe Burns

Long-Term Follow-Up Outcomes of Liver-Directed, Adeno-Associated, Vector-Mediated Gene Therapy in a Canine Model of Hemophilia A

Zanubrutinib or Ibrutinib for Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Differential Diagnosis of Bone Marrow Failure Syndromes Guided by Machine Learning

Pregnancy and Childbirth Outcomes in Women With Myeloproliferative Neoplasms

Association Between Clonal Hematopoiesis and Risk of Incident Lung Cancer

Germline Predisposition Variants Occur in Patients of All Ages With MDS

Factor IX Levels Following Etranacogene Dezaparvovec Gene Therapy in Patients With Hemophilia B

Impact of In Utero Transfusions on Perinatal Outcomes in Patients With Alpha Thalassemia Major

Associations of Clonal Hematopoiesis With Recurrent Vascular Events and Death in Patients With Incident Ischemic Stroke

Induced Pluripotent Stem Cell–Derived Platelets for Treating Alloimmune Platelet Transfusion Refractoriness

Recently Updated